Clinical Trials Browser

Phase NA × Ipilimumab × 30 days × Clear all

NCT07436390 2026-03-02

MAK

Phase NA Completed

Melanoma, Skin Neoplasms

NCT07422779 2026-02-20

MAK

Phase NA Recruiting

Melanoma, Skin Neoplasms